Oaktree Specialty Lending Corporation
NASDAQ:OCSLFinancial - Credit Services
-$0.04 today
- Market cap
- $1.05B
- Beta
- 0.57
- P/E (TTM)
- 20.5
- EPS (TTM)
- $0.56
- Dividend yield
- 13.36%
Volume 0.43M
Average 0.89M
OCSL Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Oaktree Specialty Lending CorporationNASDAQ: OCSL
Research & Development · Q2 FY2026 · quarter ended Mar 2026
Research & development remains negative
Q2 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-09-30 | 0 | — |
| FY2024 | 2024-09-30 | 0 | — |
| FY2023 | 2023-09-30 | 0 | — |
| FY2022 | 2022-09-30 | 0 | — |
| FY2021 | 2021-09-30 | 0 | — |
Research & Development vs competitors
How OCSL compares with its peers on the latest reported figures
- OCSL's LTM Mar 2026 research & development of $0 is the highest of the 11 companies compared; the peer median is $0.
- Research & development amounts to 0.0% of revenue for OCSL, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
KBDCKayne Anderson BDC, Inc. | LTM Mar 2026 | $0 | — | — | 0.0% |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding OCSL) | $0 | — | — | 0.0% | |
Competitors are the stored peer set for OCSL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Sep 2021 | FY2022 Sep 2022 | FY2023 Sep 2023 | FY2024 Sep 2024 | FY2025 Sep 2025 |
|---|---|---|---|---|---|
| Revenue | 278.82M | 86.04M | 236.85M | 186.23M | 299.7M |
| Cost of Revenue | 30.52M | 46.93M | 111.64M | 128.62M | 38.33M |
| Gross Profit | 248.31M | 39.11M | 125.2M | 57.61M | 261.37M |
| Gross Margin | 89.1% | 45.5% | 52.9% | 30.9% | 87.2% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 9.07M | 9.25M | 11.66M | 9.5M | 8.49M |
| Operating Expenses | 7.47M | 6.25M | 6.14M | (185K) | 110.35M |
| Depreciation & Amortization | 0 | 0 | 0 | 0 | 0 |
| EBITDA | 240.84M | 32.86M | 119.07M | 57.8M | 151.02M |
| EBITDA Margin | 86.4% | 38.2% | 50.3% | 31.0% | 50.4% |
| Operating Income | 240.84M | 32.86M | 119.07M | 57.8M | 151.02M |
| Operating Margin | 86.4% | 38.2% | 50.3% | 31.0% | 50.4% |
| Interest Income | 190.83M | 249.44M | 368.53M | 367.08M | 307.47M |
| Interest Expense | 30.52M | 46.93M | 111.64M | 128.62M | 115.85M |
| Other Income / Expenses | 0 | 0 | 0 | 0 | (115.85M) |
| Income Before Tax | 240.84M | 32.86M | 119.07M | 57.8M | 35.18M |
| Pre-Tax Margin | 86.4% | 38.2% | 50.3% | 31.0% | 11.7% |
| Income Tax Expense | 3.58M | 3.64M | 1.73M | (108K) | 1.26M |
| Net Income | 237.26M | 29.22M | 117.33M | 57.91M | 33.92M |
| Net Margin | 85.1% | 34.0% | 49.5% | 31.1% | 11.3% |
| EPS (Basic) | 4.39 | 0.48 | 1.63 | 0.72 | 0.39 |
| EPS (Diluted) | 4.39 | 0.48 | 1.63 | 0.72 | 0.39 |
| Weighted Avg Shares | 54.04M | 60.73M | 72.12M | 80.42M | 86.08M |
| Weighted Avg Shares (Diluted) | 54.04M | 60.73M | 72.12M | 80.42M | 86.08M |
Oaktree Specialty Lending Corporation
NASDAQ:OCSL
Intrinsic Alpha fair value
Locked
Current Price
$11.90
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.